Ventris Medical Secures FDA Clearance for Connext Surgical Matrix

The matrix is derived from highly purified Type 1 collagen sourced from bovine Achilles tendon. By leveraging the natural biological properties of this material, the dressing promotes tissue regeneration and re-epithelialization. Engineers at Ventris focused on a uniform particle size and controlled pH levels to ensure the matrix effectively absorbs wound exudates. These specifications, paired with low endotoxin levels, make the product suitable for sensitive applications, including spinal fusion surgeries.

To address the practical challenges of the operating room, Ventris developed a proprietary bellow spray system. This delivery method allows surgeons to apply the matrix precisely, even across irregular wound bed anatomies. CEO Russell Cook stated that the design specifically targets the biology of the surgical environment to support normal healing and reduce inflammatory responses. The company intends for this combination of material science and application efficiency to streamline surgical workflows while providing clinicians with a more predictable recovery path for their patients.